GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (WBO:MRCK) » Definitions » EV-to-Revenue

Merck KGaA (WBO:MRCK) EV-to-Revenue : 3.29 (As of Dec. 15, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Merck KGaA EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Merck KGaA's enterprise value is €68,901 Mil. Merck KGaA's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was €20,963 Mil. Therefore, Merck KGaA's EV-to-Revenue for today is 3.29.

The historical rank and industry rank for Merck KGaA's EV-to-Revenue or its related term are showing as below:

WBO:MRCK' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.61   Med: 3.61   Max: 5.63
Current: 3.29

During the past 13 years, the highest EV-to-Revenue of Merck KGaA was 5.63. The lowest was 2.61. And the median was 3.61.

WBO:MRCK's EV-to-Revenue is ranked worse than
60.06% of 994 companies
in the Drug Manufacturers industry
Industry Median: 2.495 vs WBO:MRCK: 3.29

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-12-15), Merck KGaA's stock price is €141.25. Merck KGaA's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was €48.22. Therefore, Merck KGaA's PS Ratio for today is 2.93.


Merck KGaA EV-to-Revenue Historical Data

The historical data trend for Merck KGaA's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA EV-to-Revenue Chart

Merck KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.62 4.11 5.48 3.94 3.36

Merck KGaA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.60 3.36 3.78 3.61 3.64

Competitive Comparison of Merck KGaA's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck KGaA's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Merck KGaA's EV-to-Revenue falls into.



Merck KGaA EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Merck KGaA's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=68900.897/20963
=3.29

Merck KGaA's current Enterprise Value is €68,901 Mil.
Merck KGaA's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €20,963 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merck KGaA  (WBO:MRCK) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Merck KGaA's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=141.25/48.221
=2.93

Merck KGaA's share price for today is €141.25.
Merck KGaA's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €48.22.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merck KGaA EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Merck KGaA's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck KGaA Business Description

Address
Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (44% of 2023 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (38%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (17%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Merck KGaA Headlines

No Headlines